JCI - Citations to HIV protease inhibitors and atherosclerosis

Citations to this article

HIV protease inhibitors and atherosclerosis

Published February 1, 2003
Citation Information: J Clin Invest. 2003;111(3):317-318. https://doi.org/10.1172/JCI17746.

View: Text | PDF

Total citations by year

Year:	2013	2010	2006	Total
Citations:	1	2	1	4

Citation information

Citations to this article (4)

Title and authors	Publication	Year
Mg supplementation attenuates ritonavir-induced hyperlipidemia, oxidative stress, and cardiac dysfunction in rats Mak IT, Kramer JH, Chen X, Chmielinska JJ, Spurney CF, Weglicki WB	American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	2013
Dendritic Cells/Natural Killer Cross-Talk: A Novel Target for Human Immunodeficiency Virus Type-1 Protease Inhibitors ML Torchia, E Ciaglia, AM Masci, L Vitiello, M Fogli, A Sala, D Mavilio, L Racioppi, D Unutmaz	PloS one	2010
Development of a novel self micro-emulsifying drug delivery system (SMEDDS) for reducing HIV protease inhibitor-induced intestinal epithelial barrier dysfunction Lei B, Zha W, Wang Y, Wen C, Stude EJ, Wang X, Jin F, Wang G, Zhang L, Zhou H	Molecular Pharmaceutics	2010
Protease inhibitors and their peptidomimetic derivatives as potential drugs Fear G, Komarnytsky S, Raskin I	Pharmacology & Therapeutics	2006

Advertisement